Atlas FDA

BRAVA CRT-D, VIVA S CRT-D, VIVA XT CRT-D

FDA premarket approval P010031/S371 · decided 2013-05-07

Approval details

PMA number
P010031
Supplement
S371
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
BRAVA CRT-D, VIVA S CRT-D, VIVA XT CRT-D
Applicant
Medtronic Cardiac Rhythm Disease Management
Date received
2013-04-09
Decision date
2013-05-07
Days to decision
28 days
Decision code
OK30
Advisory committee
Cardiovascular
Expedited review
No
Location
Mounds View, MN
Statement
SEVEN PREVIOUSLY APPROVED MANUFACTURE CHANGES FOR THE DEVICES. THOSE ARE:1) UPDATE THE CMOS IC PROCESS FLOW CHANGES AT YOUR SUPPLIER; 2) UPDATE THE TEST SOFTWARE AND HARDWARE ON THE TERADYNE TEST PLATFORM FOR M019 AND M017 ICS;3) ADD THE HIGH TEMPERATURE MONITOR TO HIGH POWER LEAN LINE; 4) UPDATE THE AUTOMATED ASSEMBLY EQUIPMENT CONTROLLER (AAEC); 5) IMPLEMENT A NEW CLEANING PROCESS AND A CURING OVEN; 6) IMPLEMENT A MANUFACTURING EXECUTION SYSTEM VERSION 7.9 AT VARIOUS INTERNAL SUPPLIERS AND FIN

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.